Skip Links

Go to homepage [Accesskey '0']
Go to content [Accesskey '1']
Go to navigation [Accesskey '2']
Search site [Accesskey '3']
Go to footer links [Accesskey '4']
Go to accessibility page [Accesskey '5']

Choose a letter

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Glossary

NDA (New Drug Application): The vehicle through which drug sponsors formally propose that the FDA approve a new drug for sale and marketing in the US.

NPL-2003: Neuropharm product in development for the treatment of Pediatric Obsessive Compulsive Disorder.

NPL-2005: Neuropharm product in development for the treatment of Fragile X syndrome.

NPL-2008: Neuropharm product in development for the treatment of autism.

NPL-2009: Neuropharm product in development for the treatment of Fragile X syndrome.